A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)
מצבים רפואיים
Chronic Spontaneous Urticaria
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
Contact: Principal Investigator (Fei Wang)Peking University People's Hospital, Beijing, Beijing, Beijing Municipality, China
Contact: Principal Investigator (cheng Zhou)Contact: Principal Investigator (Jianzhong Zhou)The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Contact: Principal Investigator (Wenlin Yang)Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China
Contact: Principal Investigator (Bin Yang)The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Contact: Principal Investigator (Guoqiang Zhang)Jingzhou Central Hospital, Jinzhou, Hubei, China
Contact: Principal Investigator (YI Sun)Wuxi Second People's Hospital,, Wuxi, Jiangsu, China
Contact: Principal Investigator (Xunyi Dai)The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Contact: Principal Investigator (Wenli Feng)The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
Contact: Principal Investigator (Songmei Geng)Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China
Contact: Principal Investigator (Xingang WU)